Clinical Trials Browser

Interventional × blinatumomab × Tumor-Agnostic × Clear all

NCT06763302 2025-01-08

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Phase NA Not yet recruiting

Neoplasm, Residual